Table 3 Data from Grayscale US, CDUS, CEUS and SE analyses of csPCa and non-csPCa nodules
Characteristic | Non-csPCa | csPCa | P |
|---|---|---|---|
Grayscale US | |||
Echogenicity, n (%) | 0.341 | ||
Hypoechoic | 62 (54.4) | 52 (45.6) | |
Other echo | 7 (70.0) | 3 (30.0) | |
Margin, n (%) | < 0.001 | ||
Clear | 22 (95.7) | 1 (4.3) | |
Unclear | 47 (46.5) | 54 (53.5) | |
Distribution, n (%) | < 0.001 | ||
Even | 38 (77.6) | 11 (22.4) | |
Uneven | 31 (41.3) | 44 (58.7) | |
Demarcation of internal and external glands, n (%) | 0.031 | ||
Clear | 58 (60.4) | 38 (39.6) | |
Unclear | 11 (39.3) | 17 (60.7) | |
Nodule size (mm) | 12.99 ± 7.10 | 16.27 ± 9.24 | 0.027 |
CDUS | |||
Adler grade, n (%) | < 0.001 | ||
Adler II–III | 26 (36.1) | 46 (63.9) | |
Adler 0–I | 43 (82.7) | 9 (17.3) | |
CEUS | |||
Enhancement patterns, n (%) | < 0.001 | ||
Synchronous wash-in or out, equal enhancement | 43 (93.5) | 3 (6.5) | |
Other patterns | 26 (33.3) | 52 (66.7) | |
SE | |||
SR | 45.51 | 83.82 | < 0.001 |